Cleared Traditional

K212326 - AC Cream - Conductive paste (FDA 510(k) Clearance)

Class II Neurology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K212326 · Spes Medica Srl · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2021
Decision
128d
Days
Class 2
Risk

K212326 is an FDA 510(k) clearance for the AC Cream - Conductive paste. Classified as Media, Electroconductive (product code GYB), Class II - Special Controls.

Submitted by Spes Medica Srl (Battipaglia, IT). The FDA issued a Cleared decision on December 1, 2021 after a review of 128 days - within the typical 510(k) review window.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1275 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Spes Medica Srl devices

Submission Details

510(k) Number K212326 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 26, 2021
Decision Date December 01, 2021
Days to Decision 128 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
20d faster than avg
Panel avg: 148d · This submission: 128d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code GYB Media, Electroconductive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1275
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GYB Media, Electroconductive

All 68
Devices cleared under the same product code (GYB) and FDA review panel - the closest regulatory comparables to K212326.
Jmoon Conductive Gel
K243749 · Shenzhen Ulike Smart Electronics Co., Ltd. · Apr 2025
Avologi Gel Primer (Model: Av25)
K220735 · Premier North America, Inc. · Sep 2023
Conductive Gel
K222770 · Top-Rank Health Care Co., Ltd. · Dec 2022
Conductive Gel
K221724 · Tone-A-Matic International, Inc. · Sep 2022
EEG-acp
K212325 · Somnomedics GmbH · Jun 2022
GT5 conductive & abrasive gel
K212787 · Wuhan Greentek Pty , Ltd. · Nov 2021